• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Mixed; Dow Rises Over 100 Points

    10/10/22 9:57:04 AM ET
    $ACMR
    $CECE
    $FIVN
    $IMUX
    Industrial Machinery/Components
    Technology
    Pollution Control Equipment
    Industrials
    Get the next $ACMR alert in real time by email

    U.S. stocks traded mixed this morning, with the Dow Jones gaining more than 100 points on Monday.

    Following the market opening Monday, the Dow traded up 0.40% to 29,412.57 while the NASDAQ fell 0.40% to 10,609.77. The S&P 500 also rose, gaining, 0.03% to 3,640.58.

    Also check this: Market Volatility Increases Following Release Of US Jobs Report


    Leading and Lagging Sectors


    Industrials shares jumped by 1.2% on Monday. Leading the sector was strength from NeoVolta Inc. (NASDAQ:NEOV) and CECO Environmental Corp. (NASDAQ:CECE).


    In trading on Monday, information technology shares fell by 1%.


    Top Headline

     

    The FDA has approved scPharmaceuticals Inc's (NASDAQ:SCPH) Furoscix (furosemide injection), a proprietary formulation of furosemide delivered via an On-Body Infusor for congestion due to fluid overload in heart failure patients.

     

    Equities Trading UP

     

    • SOBR Safe, Inc. (NASDAQ:SOBR) shares shot up 43% to $3.5705 after the company announced a relationship with a distributor with ties to air, rail and shipping industries.
    • Shares of Immunic, Inc. (NASDAQ:IMUX) got a boost, shooting 36% to $5.39 after the company announced $60 million oversubscribed private placement equity financing.
    • M-tron Industries, Inc. (NYSE:MPTI) shares were also up, gaining 10% to $16.72 after surging 10% on Friday. M-tron Industries completed its earlier announced separation from The LGL Group, Inc.


    Equities Trading DOWN

    • ACM Research, Inc. (NASDAQ:ACMR) shares tumbled 22% to $9.54 amid new US regulation tightening semiconductor exports to China.
    • Shares of Innovative Eyewear, Inc. (NASDAQ:LUCY) were down 21% to $2.09 after jumping 61% on Friday. The company recently released its October investor presentation.
    • Five9, Inc. (NASDAQ:FIVN) was down, falling 17% to $64.20 after the company's CEO resigned and accepted a position at a pre-IPO company.


    Also check out: Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday


    Commodities

    In commodity news, oil traded up 0.6% to $93.22, while gold traded down 1.7% at $1,681.10.


    Silver traded down 2.6% to $19.735 on Monday while copper rose 1.8% to $3.4475.


    Euro zone


    European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.1%, London’s FTSE 100 rose 0.1% while Spain’s IBEX 35 Index fell 0.3%. The German DAX gained 0.6%, French CAC 40 fell 0.1% and Italy’s FTSE MIB Index rose 0.1%.

     


    Economics


    There were no major US economic releases Monday


    Check out this: Ethereum Remains Above $1,300, Here Are Other Crypto Movers That Should Be On Your Radar Today


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 98,555,070 cases with around 1,087,880 deaths. India confirmed a total of at least 44,614,430 cases and 528,810 deaths, while France reported over 35,866,250 COVID-19 cases with 155,420 deaths. In total, there were at least 626,737,670 cases of COVID-19 worldwide with more than 6,561,270 deaths.

     

    Get the next $ACMR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACMR
    $CECE
    $FIVN
    $IMUX

    CompanyDatePrice TargetRatingAnalyst
    Five9 Inc.
    $FIVN
    1/5/2026$21.00Overweight → Neutral
    Piper Sandler
    Immunic Inc.
    $IMUX
    11/7/2025$3.00Buy
    Roth Capital
    Five9 Inc.
    $FIVN
    10/1/2025$28.00Equal Weight
    Wells Fargo
    NeoVolta Inc.
    $NEOV
    10/1/2025Buy → Hold
    Maxim Group
    Immunic Inc.
    $IMUX
    9/29/2025$13.00Buy
    Chardan Capital Markets
    Five9 Inc.
    $FIVN
    6/6/2025Overweight
    KeyBanc Capital Markets
    Immunic Inc.
    $IMUX
    3/25/2025Outperform
    William Blair
    ACM Research Inc.
    $ACMR
    2/28/2025$36.00Overweight
    Analyst
    More analyst ratings

    $ACMR
    $CECE
    $FIVN
    $IMUX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for FUROSCIX issued to SCPHARMACEUTICALS INC

    Submission status for SCPHARMACEUTICALS INC's drug FUROSCIX (ORIG-1) with active ingredient FUROSEMIDE has changed to 'Approval' on 10/07/2022. Application Category: NDA, Application Number: 209988, Application Classification: Type 3 - New Dosage Form

    10/11/22 1:54:57 PM ET
    $SCPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $CECE
    $FIVN
    $IMUX
    SEC Filings

    View All

    Amendment: NeoVolta Inc. filed SEC Form 8-K: Leadership Update

    8-K/A - NeoVolta Inc. (0001748137) (Filer)

    2/6/26 5:24:59 PM ET
    $NEOV
    Industrial Machinery/Components
    Miscellaneous

    ACM Research Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ACM Research, Inc. (0001680062) (Filer)

    2/6/26 8:17:57 AM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    NeoVolta Inc. filed SEC Form 8-K: Leadership Update

    8-K - NeoVolta Inc. (0001748137) (Filer)

    2/5/26 4:49:07 PM ET
    $NEOV
    Industrial Machinery/Components
    Miscellaneous

    $ACMR
    $CECE
    $FIVN
    $IMUX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis

    – Additional CALLIPER MRI Analyses Show Reductions for Vidofludimus Calcium in Acute and Chronic Inflammatory Disease Activity – – CALLIPER Subset Data Demonstrate Reductions in EBV-Specific T-Cell Receptor Sequences, Underlining Broad-Spectrum Antiviral Effects of Vidofludimus Calcium – NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Immunic, Inc. (NASDAQ:IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced the presentation of additional data from its phase 2 CALLIPER trial evaluating lead asset, nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), in patients with progressi

    2/4/26 6:30:00 AM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Five9 to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 19, 2026

    Five9, Inc. (NASDAQ:FIVN), provider of the Intelligent CX Platform, today provided details for its fourth quarter and fiscal year 2025 financial results conference call on Thursday, February 19, 2026, at 4:30 p.m. Eastern Time. Participants may register for the webinar at 4:30 p.m. Eastern Time on February 19, 2026, by clicking here. A replay will be available shortly after the conclusion of the live event. Both the live webcast and replay will be available on the Investor Relations section of the Company's website at http://investors.five9.com/. About Five9 Five9 empowers organizations to create hyper-personalized and effortless AI-driven customer experiences that deliver better bu

    2/2/26 4:05:00 PM ET
    $FIVN
    EDP Services
    Technology

    NeoVolta Announces $10 Million Equity Offering

    SAN DIEGO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- NeoVolta Inc. (NASDAQ:NEOV), a U.S.-based energy technology company delivering scalable storage, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2,100,841 shares of common stock at a purchase price of $4.76 per share in a registered direct offering. The closing of the registered direct offering is expected to occur on or about January 26, 2026, subject to the satisfaction of customary closing conditions. Needham & Company acted as sole placement agent in the registered direct offering. The aggregate gross proceeds to the Company from the offering are expected to be approximately $10

    1/23/26 8:00:00 AM ET
    $NEOV
    Industrial Machinery/Components
    Miscellaneous

    $ACMR
    $CECE
    $FIVN
    $IMUX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Officer Wang David H

    4 - ACM Research, Inc. (0001680062) (Issuer)

    2/6/26 4:30:18 PM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    Officer Mckechnie Mark exercised 31,250 shares at a strike of $19.60 and sold $1,091,507 worth of shares (31,250 units at $34.93) (SEC Form 4)

    4 - ACM Research, Inc. (0001680062) (Issuer)

    12/8/25 9:00:09 PM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    President Dignan Andy sold $166,703 worth of shares (8,212 units at $20.30), decreasing direct ownership by 4% to 207,813 units (SEC Form 4)

    4 - Five9, Inc. (0001288847) (Issuer)

    12/5/25 5:39:52 PM ET
    $FIVN
    EDP Services
    Technology

    $ACMR
    $CECE
    $FIVN
    $IMUX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Burdiek Michael J bought $24,150 worth of shares (1,000 units at $24.15), increasing direct ownership by 3% to 31,860 units (SEC Form 4)

    4 - Five9, Inc. (0001288847) (Issuer)

    8/14/25 5:01:54 PM ET
    $FIVN
    EDP Services
    Technology

    Amendment: President and COO Tardio Jason bought $9,884 worth of shares (12,512 units at $0.79) (SEC Form 4)

    4/A - IMMUNIC, INC. (0001280776) (Issuer)

    6/20/25 5:16:19 PM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: CEO and Director Vitt Daniel bought $11,550 worth of shares (15,000 units at $0.77), increasing direct ownership by 107% to 29,000 units (SEC Form 4)

    4/A - IMMUNIC, INC. (0001280776) (Issuer)

    6/20/25 5:15:45 PM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $CECE
    $FIVN
    $IMUX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Five9 downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Five9 from Overweight to Neutral and set a new price target of $21.00

    1/5/26 8:47:51 AM ET
    $FIVN
    EDP Services
    Technology

    Roth Capital initiated coverage on Immunic with a new price target

    Roth Capital initiated coverage of Immunic with a rating of Buy and set a new price target of $3.00

    11/7/25 8:30:20 AM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wells Fargo initiated coverage on Five9 with a new price target

    Wells Fargo initiated coverage of Five9 with a rating of Equal Weight and set a new price target of $28.00

    10/1/25 8:50:23 AM ET
    $FIVN
    EDP Services
    Technology

    $ACMR
    $CECE
    $FIVN
    $IMUX
    Leadership Updates

    Live Leadership Updates

    View All

    JFrog Appoints Genefa Murphy as Chief Marketing Officer to Accelerate Its Next Growth Phase

    Company Extends Executive Leadership to Lead the AI-Driven Software Supply Chain Evolution JFrog Ltd. (NASDAQ:FROG), the Liquid Software company, today announced the appointment of Genefa Murphy as Chief Marketing Officer, effective immediately. Murphy brings an expansive resume to JFrog, as a seasoned CMO and go-to-market (GTM) leader with established success in driving global enterprise software growth and strategic business expansion. Coming from software development product management roots and public company GTM leadership, Ms. Murphy also holds a PhD in User Acceptance of New Technology, from the University of Wales and is a veteran of multiple boards of directors in technology and

    1/5/26 8:00:00 AM ET
    $FIVN
    $FROG
    $HPE
    EDP Services
    Technology
    Computer Software: Prepackaged Software
    Retail: Computer Software & Peripheral Equipment

    Five9 Appoints Amit Mathradas as Next Chief Executive Officer

    Mathradas Brings a Track Record of AI Product Innovation and Delivering Operational Excellence at Scale Succeeds Long-Time CEO Mike Burkland, Who Will Remain on Board of Directors to Ensure Smooth Transition Five9, Inc. (NASDAQ:FIVN) ("Five9" or the "Company"), provider of the Intelligent CX Platform, today announced that its Board of Directors (the "Board") has appointed Amit Mathradas as the Company's Chief Executive Officer ("CEO") and a director, effective February 2, 2026. Mr. Mathradas will take on the role from Board Chairman Mike Burkland, whose decision to retire from the CEO position was announced in July. Mr. Burkland will continue to serve on the Board and will work with Mr. M

    12/17/25 8:30:00 AM ET
    $FIVN
    $AVLR
    EDP Services
    Technology

    NeoVolta Enters Into Asset Purchase Agreement for Neubau Energy's Next-Generation Battery Platform; Expects Transaction to Be Immediately Accretive to Revenues and Gross Margins

    SAN DIEGO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- NeoVolta Inc. (NASDAQ:NEOV) entered into on October 1, 2025 an asset purchase agreement for the purchase of strategic assets of Neubau Energy pursuant to its letter of intent announced on September 10, 2025 [link]. The acquisition is expected to close by October 15, 2025. Concurrently, NeoVolta hired Neubau executives, naming Amany Ibrahim as chief operating officer and Thomas Enzendorfer as chief technology officer. Michael Mendik, the company's previous chief operating officer, will continue with the company and serve as its chief product officer. "Merging Neubau's talent and next-gen battery manufacturing platform is a significant milestone

    10/7/25 7:05:00 AM ET
    $NEOV
    Industrial Machinery/Components
    Miscellaneous

    $ACMR
    $CECE
    $FIVN
    $IMUX
    Financials

    Live finance-specific insights

    View All

    Five9 to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 19, 2026

    Five9, Inc. (NASDAQ:FIVN), provider of the Intelligent CX Platform, today provided details for its fourth quarter and fiscal year 2025 financial results conference call on Thursday, February 19, 2026, at 4:30 p.m. Eastern Time. Participants may register for the webinar at 4:30 p.m. Eastern Time on February 19, 2026, by clicking here. A replay will be available shortly after the conclusion of the live event. Both the live webcast and replay will be available on the Investor Relations section of the Company's website at http://investors.five9.com/. About Five9 Five9 empowers organizations to create hyper-personalized and effortless AI-driven customer experiences that deliver better bu

    2/2/26 4:05:00 PM ET
    $FIVN
    EDP Services
    Technology

    NeoVolta Reports Record First Quarter Fiscal 2026 Results

    SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) -- NeoVolta Inc. (NASDAQ: NEOV), a U.S.-based energy technology company delivering scalable storage, for resilient residential and commercial power infrastructure, today announced financial results for its first quarter of fiscal 2026, which ended September 30, 2025. "Our first quarter performance demonstrates the strength of our multi-channel growth strategy and the increasing market adoption of distributed energy storage solutions," said Ardes Johnson, Chief Executive Officer of NeoVolta. "We delivered $6.7 million in revenue, representing over 1,000% year-over-year growth and marking our fourth consecutive record quarter. This momentum reflec

    11/11/25 8:30:00 AM ET
    $NEOV
    Industrial Machinery/Components
    Miscellaneous

    ACM Research Reports Third Quarter 2025 Results

    FREMONT, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- ACM Research, Inc. ("ACM") (NASDAQ:ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today reported financial results for its third quarter ended September 30, 2025. "I am pleased to report another strong quarter for ACM. We grew revenue by 32%, and continue to innovate with world-class tools across multiple product lines. We believe the market is moving toward ACM as AI and global datacenter investments are demanding new innovative technology requirements for next generation semiconductor equipment," said Dr. David Wang, President and Chief Executive Officer of ACM.

    11/5/25 7:00:00 AM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    $ACMR
    $CECE
    $FIVN
    $IMUX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Five9 Inc.

    SC 13G - Five9, Inc. (0001288847) (Subject)

    11/21/24 6:17:26 AM ET
    $FIVN
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by scPharmaceuticals Inc.

    SC 13G/A - scPharmaceuticals Inc. (0001604950) (Subject)

    11/15/24 4:06:50 PM ET
    $SCPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by scPharmaceuticals Inc.

    SC 13G/A - scPharmaceuticals Inc. (0001604950) (Subject)

    11/14/24 5:48:35 PM ET
    $SCPH
    Biotechnology: Pharmaceutical Preparations
    Health Care